SCHEMBL17628112

SCHEMBL17628112

O=C(O)NC1CCCN(c2nc(Cl)nc3c2CCCC3)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.45
PRKDC P78527 2/20 0.38
CNR1 P21554 1/20 0.37
BTK Q06187 4/20 0.36
TSHR P16473 4/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
JAK3 P52333 1/20 0.35
PPARA Q07869 3/20 0.35
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 1/20 0.34
NR4A1 P22736 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
OPRM1 P35372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17628018 0.98 HRH4 (0.45) HRH4PRKDCCNR1BTKTSHR
SCHEMBL17628082 0.92 HRH4 (0.51) HRH4TSHRKMT2ALMNANR4A1
SCHEMBL17628042 0.90 HRH4 (0.46) HRH4PRKDCBTKJAK3OPRM1
SCHEMBL17628039 0.90 HRH4 (0.46) HRH4PRKDCBTKJAK3OPRM1
SCHEMBL17628230 0.87 HRH4 (0.46) HRH4PRKDCBTKTSHRJAK3
SCHEMBL17628231 0.87 HRH4 (0.46) HRH4PRKDCBTKTSHRJAK3
SCHEMBL17628415 0.84 BTK (0.54) HRH4BTKJAK3
SCHEMBL17628416 0.84 BTK (0.54) HRH4BTKJAK3
SCHEMBL17628467 0.84 HRH4 (0.53) HRH4OPRM1OPRK1OGFRL1
SCHEMBL17628466 0.84 HRH4 (0.53) HRH4OPRM1OPRK1OGFRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORPORATION (KR) 2017-06-01 US disclosed
EP-3006439-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR Yuhan Corporation (KR) 2016-04-13 EP disclosed
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORP (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 HRH4 4/4885PRKDC 4342/4885CNR1 868/4885
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 HRH4 4/4885PRKDC 4342/4885CNR1 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.